NCT05940324PHASE2RecruitingAccepts Healthy Volunteers
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Stanford University
Start Date
2/24/2024
Completion Date
11/1/2028
Summary
The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.
Detailed Description
The proposed mechanistic trial would be the first to probe the role of ketamine's opioid properties in modulating fronto-striatal circuitry and bringing about reduction of OCD symptoms.
Eligibility Criteria
Age Range: 18 years to 65 years
Eligibility Criteria for Participants with OCD:
Inclusion Criteria:
* Ages 18-65
* Meet the criteria for OCD diagnosis
* Failed at least 1 prior trial of standard first-line OCD treatment
* Agree to the following lifestyle modifications: comply with requirements for fasting prior to the Experimental Session, not enroll in any other interventional clinical trials during the duration of the study, and commit to medication study procedures.
* Able to provide informed consent
Exclusion Criteria:
* prior naltrexone or ketamine use/exposure
* Any current or past medical/psychiatric condition that makes participation unsafe in the opinion of the investigator or study physician
* Pregnant or nursing, or able to become pregnant and are not practicing an effective means of birth control
* the presence of metal in the body that is contraindicated for MRI scans
Eligibility Criteria for Healthy Volunteers:
Inclusion Criteria:
* Ages 18-65
* Able to provide informed consent
Exclusion Criteria:
* current or past use of psychotropic medication
* pregnant or nursing females
* the presence of metal in the body that is contraindicated for MRI scans
Interventions
DRUG
Ketamine
DRUG
Naltrexone Pill
OTHER
Placebo pill
Conditions
Obsessive-Compulsive Disorder
Locations
Department of Psychiatry & Behavioral Sciences
Stanford, California 94305
United States